{"id":420652,"date":"2019-08-19T23:58:01","date_gmt":"2019-08-19T23:58:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=420652"},"modified":"2019-08-19T23:58:01","modified_gmt":"2019-08-19T23:58:01","slug":"nonalcoholic-steatohepatitis-biomarkers-market-size-to-expand-at-a-dazzling-cagr-of-2092-up-to-2024-mrfr","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/nonalcoholic-steatohepatitis-biomarkers-market-size-to-expand-at-a-dazzling-cagr-of-2092-up-to-2024-mrfr_420652.html","title":{"rendered":"Non-Alcoholic Steatohepatitis Biomarkers Market Size to Expand at a Dazzling CAGR of 20.92% up to 2024 | MRFR"},"content":{"rendered":"
\"Non-Alcoholic<\/a><\/p>\n
\n
Non-Alcoholic Steatohepatitis Biomarkers Market<\/div>\n<\/div>\n<\/div>\n
The report titled Global Non-Alcoholic Steatohepatitis Biomarkers Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover market size, growth rate, opportunities, market Dynamics and Factor Analysis.\n<\/div>\n

The Global Non-Alcoholic Steatohepatitis Biomarkers Market is Expected to Register a CAGR of 20.92% and is Anticipated to Reach USD 1,960.4 Million by 2024. Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD), which is characterized by liver inflammation and damage caused by a buildup of fat in the liver. Currently, there are no noninvasive diagnostic tools approved for non-alcoholic steatohepatitis.<\/p>\n

Growing prevalence of NASH, increasing demand for non-invasive diagnostic tests, and rising initiatives for creating awareness are some major factors propelling the growth of the market. Additionally, the rising prevalence of diabetes and obesity is likely to support market growth. On the hand, the presence of stringent regulations by the US FDA for the qualification of biomarkers is anticipated to restrict the market growth during the assessment period.<\/p>\n

Request Free Sample Copy at<\/strong> https:\/\/www.marketresearchfuture.com\/sample_request\/7984<\/a><\/p>\n

Top Players: <\/strong><\/p>\n

Market Research Future (MRFR) recognizes the following companies as the key players in the global non-alcoholic steatohepatitis biomarkers market that includes are BioPredictive (France), Celerion (US), Cisbio (France), Echosens (France), Enterome (France), GENFIT (France), Laboratory Corporation of America Holdings (US), NGM Biopharmaceuticals (US), One Way Liver, SL (Spain), Pacific Biomarkers (US), Prometheus Laboratories Inc (US), Perspectrum Diagnostics Ltd (UK), Quest Diagnostics, Regulus Therapeutics, Inc. (US), Siemens Healthineers (Germany), Shenzhen New Industries Biomedical Engineering Co., Ltd (China), and Xeptagen SpA (Italy)<\/p>\n

Market Segmentation <\/strong><\/p>\n

The global non-alcoholic steatohepatitis biomarkers market has been segmented by into type and end user. By type, the market has been segmented into serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers, and others. By end user, the market has been segmented into pharmaceutical companies and CROs, research institutes and academics, hospitals & clinics, diagnostic centers, and others.<\/p>\n

Global Non-Alcoholic Steatohepatitis Biomarkers Market   – Regional Analysis<\/strong><\/p>\n

Geographically, the Americas is expected to dominate the global non-alcoholic steatohepatitis biomarkers market. The growth in this region can be attributed to the favorable government initiatives, the presence of sophisticated healthcare infrastructure, and rising prevalence of diabetes, fatty liver disease, and obesity. Europe is anticipated to hold the second position in the global market owing to the factors such as growing incidence of NASH, increasing prevalence of obesity and diabetics, and increasing research and development on liver diseases. In the Asia-Pacific region, the market growth is mainly due to the factors such as the presence of a large patient base, increase in healthcare spending, and availability of skilled healthcare personnel. The Middle East and Africa is anticipated to register the lowest share in the global market. In the African region, the market is likely to be negatively affected by factors such as poor healthcare infrastructure, less disposable income, limited awareness about liver diseases, including NASH.<\/p>\n

TOC:<\/strong><\/p>\n

1  Executive Summary$ 1,350.00<\/p>\n

2  Market Introduction$ 0.00<\/p>\n

3  Research Methodology$ 0.00<\/p>\n

4  Market Dynamics$ 950.00<\/p>\n

5  Market Factor Analysis$ 950.00<\/p>\n

6  Global Non-Alcoholic Steatohepatitis Biomarkers Market, by Type$ 1,650.00<\/p>\n

7  Global Non-Alcoholic Steatohepatitis Biomarkers Market, by End User$ 1,650.00<\/p>\n

8  Global Non-Alcoholic Steatohepatitis Biomarkers Market, by Region$ 1,650.00<\/p>\n

9  Competitive Landscape$ 1,050.00<\/p>\n

10  Company Profiles<\/p>\n

Continued…<\/strong><\/p>\n

Get Full Report with Top Industry Players and Segments at <\/strong>https:\/\/www.marketresearchfuture.com\/reports\/non-alcoholic-steatohepatitis-biomarkers-market-7984<\/a><\/p>\n

About Market Research Future:<\/strong><\/p>\n

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future<\/a>
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/non-alcoholic-steatohepatitis-biomarkers-market-7984<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Non-Alcoholic Steatohepatitis Biomarkers Market The report titled Global Non-Alcoholic Steatohepatitis Biomarkers Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover market size, growth rate, opportunities, market Dynamics and Factor Analysis. The Global Non-Alcoholic Steatohepatitis … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[406,403,404,416],"tags":[],"class_list":["post-420652","post","type-post","status-publish","format-standard","hentry","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/420652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=420652"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/420652\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=420652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=420652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=420652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}